ThanassoulisG.Screening for high lipoprotein(a). Circulation2019;
139: 1493–1496.
2.
NordestgaardBGChapmanMJRayK, et al.
Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J2010;
31: 2844–2853.
3.
ClarkeRPedenJFHopewellJC, et al.
Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med2009;
361: 2518–2528.
4.
GrundySMStoneNJBaileyAL, et al.
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol2019;
73: e285–e350.
5.
SinghACollinsBLGuptaA, et al.
Cardiovascular risk and statin eligibility of young adults after an MI: Partners YOUNG-MI Registry. J Am Coll Cardiol2018;
71: 292–302.
6.
CaoJSteffenBTGuanW, et al.
Evaluation of lipoprotein(a) electrophoretic and immunoassay methods in discriminating risk of calcific aortic valve disease and incident coronary heart disease: the multi-ethnic study of atherosclerosis. Clin Chem2017;
63: 1705–1713.
7.
BaudhuinLMHartmanSJO’BrienJF, et al.
Electrophoretic measurement of lipoprotein(a) cholesterol in plasma with and without ultracentrifugation: comparison with an immunoturbidimetric lipoprotein(a) method. Clin Biochem2004;
37: 481–488.
8.
GoffDCJrLloyd-JonesDMBennettG, et al.
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol2014;
63: 2935–2959.
9.
MachFBaigentCCatapanoAL, et al.
2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J2020;
41: 111–188.
10.
Fernandez-LabanderaCCalvo-BonachoEValdivielsoP, et al. Prediction of fatal and non-fatal cardiovascular events in young and middle-aged healthy workers: the IberScore model. Eur J Prev Cardiol. Epub ahead of print 18 December 2019. DOI: 10.1177/2047487319894880.
11.
MeirhaegheAMontayeMBiaschK, et al. Coronary heart disease incidence still decreased between 2006 and 2014 in France, except in young age groups: results from the French MONICA registries. Eur J Prev Cardiol. Epub ahead of print 26 February 2020. DOI: 10.1177/2047487319899193.
12.
SinghAGuptaACollinsBL, et al.
Familial hypercholesterolemia among young adults with myocardial infarction. J Am Coll Cardiol2019;
73: 2439–2450.
13.
YangJBieryDWSinghA, et al. Risk factors and outcomes of very young adults who experience myocardial infarction: the Partners YOUNG-MI Registry. Am J Med. Epub ahead of print 13 November 2019. DOI: 10.1016/j.amjmed.2019.10.020.
14.
TsimikasSKarwatowska-ProkopczukEGouni-BertholdI, et al.
Lipoprotein(a) reduction in persons with cardiovascular disease. N Engl J Med2020;
382: 244–255.
